Health Grants

Health Resources and Services Administration · $1M–$1.6M

This HRSA Medical Student Education program funds public medical schools in states with projected primary care provider shortages to expand education for future physicians. Eligibility is narrow: only accredited public medical schools in a small set of identified shortage states, and schools currently receiving MSE funding are excluded. Awards range from about $1,000,000 to $1,625,000. Most organizations and individuals are not eligible.

National Institutes of Health · Up to $499K

This NIH/National Cancer Institute R01 award funds projects to improve the reliability and translational usefulness of mammalian cancer and tumor models, with no clinical trials allowed. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. The stated maximum award is about $499,000. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Up to $500K

This NIH (NIAAA) R01 award funds health services research aimed at closing the treatment gap for alcohol use disorder, including improving access to and appeal of treatment and reducing disparities. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. The stated maximum award is about $500,000. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH/National Cancer Institute R01 award supports assay development and screening to discover small-molecule chemical probes, drugs, or immunomodulators, with no clinical trials allowed. It is aimed at research institutions and investigators conducting early-stage discovery research, and lists a broad set of eligible U.S. organization types. Funding amounts are not specified here. Applications are submitted through eligible organizations.

National Institutes of Health · Up to $500K

This NIH (NIAAA) R01 award funds treatment, pharmacotherapy, and recovery research for alcohol use disorder, including medications development, behavioral therapies, and recovery science; a clinical trial is required. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. The stated maximum award is about $500,000. Applications are submitted through eligible organizations.

National Institutes of Health · Amount varies

This NIH R21 award funds exploratory translational research on schizophrenia and related disorders in mid- to late-life, aiming to understand illness trajectory and identify prevention and treatment targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations.

National Institutes of Health · Amount varies

This NIH (NIAAA) R34 award supports planning and pilot health services research aimed at closing the treatment gap for alcohol use disorder. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here, though R34 grants are typically smaller, planning-stage awards. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R01 award funds research into the mechanisms behind neuropsychiatric symptoms in Alzheimer's disease and related dementias, with the goal of identifying novel therapeutic targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R21 award funds exploratory research into the mechanisms behind neuropsychiatric symptoms in Alzheimer's disease and related dementias, with the aim of revealing novel therapeutic targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH (NIAAA) R34 award supports planning and pilot research on alcohol use disorder treatment and recovery; a clinical trial is required. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here, though R34 grants are typically smaller, planning-stage awards. Applications are submitted through eligible organizations.

National Institutes of Health · Amount varies

This NIH R01 award funds translational research on schizophrenia and related disorders in mid- to late-life, aiming to clarify illness trajectory and identify prevention and treatment targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R01 award funds research on how social isolation and loneliness raise suicide risk in older adults, including mechanism studies and intervention development and testing. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

The goal of this NOFO is to support doctoral candidates from a variety of academic disciplines for up to two years for the completion of the doctoral dissertation research project. Research projects should align with NIDA funding priorities detailed here (https://www.drugabuse.gov/funding/funding-priorities). This award will facilitate the entry of promising new investigators into the field of substance use/substance use disorder (SU(D) research, enhancing the pool of highly talented SU(D) researchers.

National Institutes of Health · Amount varies

This Funding Opportunity Announcement (FOA) encourages grant applications for Biomedical Technology Resource Centers (BTRCs). BTRCs are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. BTRCs also make their technologies available to other investigators, train members of the research community in the use of the technologies, and disseminate the technologies broadly.

National Institutes of Health · Amount varies

This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of neural function. For the purposes of this NOFO, the term complex can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. Studies may be either hypothesis-generating (unbiased discovery) or hypothesis-testing in design and may utilize in vivo, in situ or in vitro experimental paradigms, e.g., model organisms or human cell-based assays. While behavioral paradigms and outcome measures can be incorporated into the research design to facilitate the characterization of intracellular, transcellular, and circuit mechanisms, these are neither required nor expected. Studies should not attempt to model disorders but instead should aim to elucidate the neurobiological impact of individual or combined risk factor(s), such as the affected molecular and cellular components and their relationships within defined biological process(es). This can include the fundamental biology of these factors, components, and processes. The resulting paradigms, component pathways, and biological processes should be disseminated with sufficient detail to enrich common and/or federated data resources (e.g., those contributing to the Gene Ontology, Synaptic Gene Ontology, FAIR Data Informatics) in order to bridge the gap between disease risk factors, biological mechanism and therapeutic target identification. The present NOFO (R01 activity code) can be used for applications to further develop lines of inquiry where feasibility or proof-of-concept has been established. Applicants proposing exploratory research at the early and conceptual stages of project development should apply to the companion R21 NOFO PAR-24-025

National Institutes of Health · Amount varies

This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in late-life. Emphasis is placed on research that identifies neurobiological and environmental mechanisms associated with social isolation and loneliness that increase risk for suicidal thoughts and behavior in late-life, that uses an experimental therapeutics approach to identify targets and develop and test interventions to prevent late-life suicide, and that develops new and modifies existing service delivery models to enhance social connection in late-life to prevent suicide.

National Institutes of Health · Amount varies

This NIH R21 award supports early-stage, high-risk exploratory research into the cellular, molecular, and circuit biology of risk factors for complex brain disorders, with no clinical trials allowed. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH/National Cancer Institute award funds NCORP Research Bases that serve as research hubs designing and running multi-institution cancer control, prevention, and care-delivery clinical trials. It is aimed at established research organizations with the scientific, statistical, and data-management infrastructure to lead a community oncology research network. Foreign organizations and foreign components of U.S. organizations are not eligible. Eligibility details are in the NOFO, so review Section III before applying.

National Institutes of Health · Amount varies

This NIH/NCI program (UG1) funds NCORP Academic Community Sites, which are consortia led by an academic center with affiliated community hospitals and oncology practices, to broaden participation in cancer control, prevention, treatment, and care-delivery studies. Eligibility centers on academic medical centers with the infrastructure to support accrual across affiliates; foreign organizations and foreign components are not eligible. No award amount is stated. This is restricted to qualifying academic-led community research consortia, not general applicants.

National Institutes of Health · Amount varies

This NIH/NCI program (UG1) funds NCORP Community Sites, which are healthcare systems or consortia of community hospitals, oncology practices, public hospitals, or health centers that broaden participation in cancer control, prevention, treatment, and care-delivery research. Eligibility centers on healthcare systems and community-based oncology networks; foreign organizations and foreign components are not eligible. No award amount is stated. This is aimed at community healthcare organizations participating in NCORP, not individuals or general nonprofits.